Restricción del crecimiento intrauterino: perspectiva endocrinológica. Resumen

Endocrinología, Comité Nacional de

doi:10.5546/aap.2017.s63

Cited by 1 publication

(2 citation statements)

References 23 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finken et al (2006) reported that approximately 20% of a total of 380 adolescents with a history of prematurity of adequate weight for GA developed postnatal growth retardation and a greater prevalence of short height [37]. Similarly, 10-15% of adults with a history of IUGR continue to have a short stature in adulthood, and growth hormone treatment has even been approved for this condition [38,39]. Moreover, it has been observed that prepubertal EUGR children present a greater risk of having lower weight, which has historically been associated with prematurity rather than specifically with EUGR or IUGR itself [28].…”

Section: Discussionmentioning

confidence: 99%

“…The reference group included healthy young adult volunteers who met the following inclusion criteria at the time of measurement: pubertal stage (Tanner ≥ III regardless the age), born at term with adequate weight and height for GA (38)(39)(40)(41)(42) weeks GA and 2500-3500 g at birth), no relevant antecedents of metabolic disease, and confirmed to be free of any diseases through comprehensive physical and biochemical evaluation. The exclusion criteria for both groups were chronic disease and smoking.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Metabolic and Low-Grade Inflammation Risk in Young Adults with a History of Extrauterine Growth Restriction

Palomino-Fernández,

Pastor-Villaescusa,

Velasco

et al. 2024

Nutrients

View full text Add to dashboard Cite

Children with a history of extrauterine growth restriction (EUGR), later at prepubertal age, exhibit an increased metabolic risk including risen insulin resistance and low-grade inflammation. However, the progression of such metabolic changes after puberty and the lasting health implications have not yet been investigated. The objective of this study was to ascertain whether young adults with a history of EUGR faced increased vulnerability to metabolic disorders. A study was conducted comparing a group of adults with a history of EUGR with a healthy reference group. A total of 110 young adults (36 from the EUGR group and 74 from the control group) were included. Anthropometric variables, blood pressure (BP), general biochemical parameters, plasma inflammatory biomarkers, and adipokines were assessed. Compared to the reference group, the EUGR group had a shorter height and body weight with higher lean mass and waist circumference, as well as a greater percentage of individuals with high BP. In addition, EUGR patients had higher values of insulin, HOMA-IR, nerve growth factor, and leptin, and lower levels of adiponectin and resistin. The present study suggests that young adults with a history of EUGR present increased metabolic risk factors therefore, clinical follow-up should be considered.

show abstract